Non-specific code 2014 ICD-9-CM Diagnosis Code 205.0
Myeloid leukemia acute
  • Non-Billable Code
  • There are 3 ICD-9-CM codes below 205.0 that define this diagnosis in greater detail. Do not use this code on a reimbursement claim.
Clinical Information
  • A clonal expansion of myeloid blasts in the bone marrow, blood or other tissues. The classification of acute myeloid leukemias (amls) encompasses four major categories: 1) aml with recurrent genetic abnormalities 2) aml with multilineage dysplasia 3) therapy-related aml 4) aml not otherwise categorized. The required bone marrow or peripheral blood blast percentage for the diagnosis of aml has been recently reduced from 30% (french-american-british [fab] classification) to 20% (who classification). (who, 2001)
  • A quickly progressing disease in which too many immature blood-forming cells are found in the blood and bone marrow.
  • A type of acute myeloid leukemia, a quickly progressing disease in which too many immature blood-forming cells are found in the blood and bone marrow.
  • Acute leukemia arising from myeloid tissue in which the granular, polymorphonuclear leukocytes and their precursors predominate.
  • An acute myeloid leukemia (aml) in which abnormal promyelocytes predominate. It is characterized by the t(15;17)(q22;q12) translocation. There are two variants: the typical and micro granular (hypo granular) variant. This aml is particularly sensitive to treatment with all trans-retinoic acid and has a favorable prognosis. (who, 2001)
  • Leukemia commonly occurring after alkylating agent treatment; manifestations include pancytopenia, megaloblastic bone marrow, and nucleated red cells in peripheral marrow; patients usually have chromosomal abnormalities in marrow cells.
205.0 Excludes
  • acute exacerbation of chronic myeloid leukemia (205.1)
Applies To
  • Acute promyelocytic leukemia
ICD-9-CM Volume 2 Index entries containing back-references to 205.0:
  • Leukemia, leukemic (congenital) (M9800/3) 208.9
    • blastic (M9801/3) 208.0
      • granulocytic (M9861/3) 205.0
    • granulocytic (M9860/3) 205.9
      • acute (M9861/3) 205.0
      • aleukemic (M9864/3) 205.8
      • blastic (M9861/3) 205.0
      • chronic (M9863/3) 205.1
      • subacute (M9862/3) 205.2
      • subleukemic (M9864/3) 205.8
    • myeloblastic (M9861/3) 205.0
    • myelocytic (M9863/3) 205.1
      • acute (M9861/3) 205.0
    • myelogenous (M9860/3) 205.9
      • acute (M9861/3) 205.0
      • aleukemic (M9864/3) 205.8
      • chronic (M9863/3) 205.1
      • monocytoid (M9863/3) 205.1
      • subacute (M9862/3) 205.2
      • subleukemic (M9864) 205.8
    • myeloid (M9860/3) 205.9
      • acute (M9861/3) 205.0
      • aleukemic (M9864/3) 205.8
      • chronic (M9863/3) 205.1
      • subacute (M9862/3) 205.2
      • subleukemic (M9864/3) 205.8
    • myelomonocytic (M9860/3) 205.9
      • acute (M9861/3) 205.0
      • chronic (M9863/3) 205.1
    • promyelocytic, acute (M9866/3) 205.0
  • Myelosis (M9860/3) (see also Leukemia, myeloid) 205.9
    • acute (M9861/3) 205.0
ICD-9-CM codes are used in medical billing and coding to describe diseases, injuries, symptoms and conditions. ICD-9-CM 205.0 is one of thousands of ICD-9-CM codes used in healthcare. Although ICD-9-CM and CPT codes are largely numeric, they differ in that CPT codes describe medical procedures and services. Can't find a code? Start at the root of ICD-9-CM, check the 2014 ICD-9-CM Index or use the search engine at the top of this page to lookup any code.